TNF and inflammatory bowel disease: Precision-guided dosing (PGD) is a TDM-supported, model-informed precision dosing (MIPD) approach designed for two of the most commonly used anti-TNFα in IBD, IFX and adalimumab (ADA) [30], or their biosimilars.